Balancing sample size and accuracy of dose selection in phase 1 oncology trials – designs tiered by cohort size and maximum number of patients treated per dose

Journal of Biopharmaceutical Statistics · Published 2026-07-26 · DOI 10.1080/10543406.2026.2699850

Free full text

Authors (5)

Ping Gao, Xun Zhang, Weidong Zhang, Meng Li, Chunming Zhang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Gao, P., Zhang, X., Zhang, W., et al. (2026). Balancing sample size and accuracy of dose selection in phase 1 oncology trials – designs tiered by cohort size and maximum number of patients treated per dose. Journal of Biopharmaceutical Statistics. https://doi.org/10.1080/10543406.2026.2699850

Related articles

• Statistical approaches to classify investigational product using hERG safety assay · Journal of Biopharmaceutical Statistics · 2026 · Same journal
• Advances in statistical methodologies for assessing bioequivalence of topical dermatological products · Journal of Biopharmaceutical Statistics · 2026 · Same journal
• Real-world data and evidence in the development of cell and gene therapies · Journal of Biopharmaceutical Statistics · 2026 · Same journal
• Robust CATE estimation using novel ensemble methods · Journal of Biopharmaceutical Statistics · 2026 · Same journal
• Augmented match weighted estimators: new methods for estimating average treatment effects under extreme propensity scores · Journal of Biopharmaceutical Statistics · 2026 · Same journal
• Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes · Journal of Biopharmaceutical Statistics · 2026 · Same journal
• Non-inferiority testing for the odds ratio in two independent binomial proportions using the method of variance estimates recovery · Journal of Biopharmaceutical Statistics · 2026 · Same journal
• Bayesian quantitative decision-making framework in cell and gene therapy development for rare diseases · Journal of Biopharmaceutical Statistics · 2026 · Same journal
• Analyze paired case–control data prospectively in comparing two predictive values · Journal of Biopharmaceutical Statistics · 2026 · Same journal
• Parallelism of four-parameter logistic bioassay models: equivalence testing for parameter differences* · Journal of Biopharmaceutical Statistics · 2026 · Same journal